Rezolute, Inc. |
CFO |
Common Shares |
121K |
$490K |
$4.04 |
Jun 14, 2024 |
Direct |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
134K |
$296K |
$2.20 |
May 24, 2021 |
Direct |
Rezolute, Inc. |
CFO |
Common Shares |
40K |
$162K |
$4.04 |
Jun 14, 2024 |
Held by PoC Capital, LLC |
Rezolute, Inc. |
CFO |
Common Shares |
20K |
$80.8K |
$4.04 |
Jun 14, 2024 |
Held by spouse |
Rezolute, Inc. |
CFO |
Common Shares |
13K |
$52.5K |
$4.04 |
Jun 14, 2024 |
Held by minor child #1 |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
8.95K |
$19.7K |
$2.20 |
May 27, 2021 |
By UTMA #1 |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
8.67K |
$19.1K |
$2.20 |
May 27, 2021 |
By UTMA #2 |
Rezolute, Inc. |
CFO |
Common Shares |
4.5K |
$18.2K |
$4.04 |
Jun 14, 2024 |
Held by minor child #2 |
Rezolute, Inc. |
CFO |
Common Shares |
4.5K |
$18.2K |
$4.04 |
Jun 14, 2024 |
Held by minor child #3 |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
6.11K |
$13.5K |
$2.20 |
May 24, 2021 |
By PoC Capital, LLC |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
888 |
$1.96K |
$2.20 |
May 24, 2021 |
By UTMA #3 |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
888 |
$1.96K |
$2.20 |
May 24, 2021 |
By UTMA #4 |
Rezolute, Inc. |
CFO |
Employee Stock Option (Right to Buy) |
275K |
|
|
Jan 23, 2024 |
Direct |
Rezolute, Inc. |
CFO |
Employee Stock Option (Right to Buy) |
100K |
|
|
Sep 23, 2024 |
Direct |
NEPHROS INC |
CEO Specialty Renal Products |
Stock Option (Right to Buy) |
20K |
|
|
May 24, 2021 |
Direct |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock Warrants (Right to Buy) |
0 |
|
|
May 24, 2021 |
By UTMA #1 |
NEPHROS INC |
CEO Specialty Renal Products |
Common Stock Warrants (Right to Buy) |
0 |
|
|
May 24, 2021 |
By UTMA #2 |